Cannabis Report
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, BZstocks, DDStocks, HighYieldStocks, Mykkus, SK510
Search This Board: 
Last Post: 8/15/2018 2:12:03 AM - Followers: 525 - Board type: Free - Posts Today: 6

Welcome to the Ihub Arrayit Corporation (ARYC) board  

Arrayit Corporation (ARYC) is a Silicon Valley biotech company that is currently trading at a low fraction of its actual worth. Please review the listed links, see the actual sales of this Silicon Valley company through their daily updates on Twitter (@Arrayit) and understand the incredible potential that this company has.  

Arrayit Corporation  
927 Thompson Place  
Sunnyvale, CA 94085  
Phone 408-744-1331  
FAX 408-744-1711  


Publications and Social Networking:  

Arrayit products have been featured in 5,000+ scientific publications.
Follow Arrayit on Twitter, Facebook, Yahoo Finance, $ARYC and iHub. 
Arrayit Corporation News Feed
Arrayit Store
Corporate Overview
Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.
Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries. Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.

No share increase per CEO (I.E. NO DILUTION)

Authorized: 2,480,000,000 
Outstanding: 1,055,279,527 
Restricted: 11,490,723 
Float: 1,043,788,804 

Standard Registrar and Transfer Company, Inc. 
440 East 400 South, Suite 200 
Salt Lake City, UT 84111 
Phone: 801-571-8844 or 801-596-2150 
Fax: 801-328-4058

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 

2 contracts signed last year for a total of approximately $51 million over the next 3 years ......

No other OTC company has the potential of ARYC  

Arrayit's new corporate headquarters, features 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities

Arrayit Headquarters Drive By(Click to view)
Arrayit Store sales exceed $55,000,000 all time on 230,706 products and services sold since on-line inception



ARYC also owns 40 million shares of AVDX(Click to visit Advant Diagnostics)

Enabling physicians to make personalized treatment recommendations for cancer patients

Avant Diagnostics, Inc. (formerly known as Theranostics Health, Inc.) is a medical diagnostic technology company focused on commercializing innovative biomarker technologies that have the potential to dramatically improve treatment outcomes in the areas of oncology and neurology. The Company's lead technology, called Theralink(r), was developed to empower cancer treating physicians with actionable information make time sensitive treatment decisions for their patients. Theralink was designed to inform physicans which treatments are likely to be effective for their patients at any given moment in time, and also identify which treamtents are unlikely to be effective. This information has the potential to improve treatment efficacy and reduce side effects by foregoing ineffective therapy.

Cancer tumor biomarker profiling: Driving innovation in personalized medicine

At Avant Diagnostics, our approach is based on more than 10 years of research and development that informs our philosophy the genetic information alone is insufficient to make patient specific treatment recommendations. Our phospho-proteomic approach, which focuses on measuring the quantity and intensity of drug target activation in the tumor tissue following standard biopsy procedures, exploits our understanding of drug-receptor interaction that is the driver of treatment response . Our advanced technology is being developed to reduce the prescription of ineffective, toxic treatments and guide physicians towards therapies that are most likely to lead to positive responses to treatment. Our large panel of markers targeted at already-approved FDA drugs, as well as certain investigational therapies, makes Theralink an invaluable tool for oncologists.

Market opportunity: Cancer biomarkers market expected to reach $33B by 2025

According to Grand View Research, the market for cancer biomarkers is expected to grow from $10.3B in 2016 to $33.7B by 2025, representing a compound annual growth rate (CAGR) of 14.6%. The market is currently comprised primarily of genetic biomarkers that have good predictive value on a population basis, but limited value on an individual patient basis. Proteomic markers represent a growing segment of the cancer biomarker market, and offer the promise to improve individual patient outcomes based upon the individual patient's tumor proteomic profile.

Within the proteomic cancer biomarker category, phosphoprotein analysis represents a uniquely positioned asset class that can more robustly predict treatment outcomes based upon the molecular mechanisms driving tumor growth and treatment resistance. As such, the Company believes it has the potential to be the market leader in this phospho-proteomic subcategory.

OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.

Human genome

Arrayit Corporation Announces New Clinical Licensure

from the Centers for Medicare and Medicaid Services - 


Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARYC News: Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain 08/13/2018 05:30:00 AM
ARYC News: Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics 07/30/2018 05:30:00 AM
ARYC News: Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration 07/16/2018 05:30:00 AM
ARYC News: Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains 07/02/2018 05:30:00 AM
ARYC News: Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network 06/18/2018 05:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#93926  Sticky Note Arrayit Corp Receives Approval for In-Store Promotions by techmover 08/14/18 01:31:57 PM
#88018  Sticky Note Updated- ARYC Potential revenue streams partial list: BZstocks 07/10/18 08:25:45 PM
#87486  Sticky Note ARYC BOARD NEWBIES aboard??? MUST READ DD HighYieldStocks 07/04/18 11:33:29 AM
#87017  Sticky Note New investors of Arrayit Corporation [OTC: ARYC] DDStocks 06/30/18 02:55:19 PM
#78352  Sticky Note Welcome to all new investors and those inquiring SK510 05/02/18 06:50:16 PM
#78280  Sticky Note Silicon Valley Biotech Mykkus 05/02/18 02:28:23 PM
#93988   Hugie, maybe YOU should sell before summer is over? Ace508 08/15/18 02:12:03 AM
#93987   Hi Stevenson, thanks for ur concern whether this Starlight84 08/15/18 02:09:38 AM
#93986   As soon as the Summer past it can Hugie 08/15/18 01:36:40 AM
#93985   Oh ok, still not enough to smile? And TravO 08/15/18 01:32:56 AM
#93984   May be 90 000 is for some people Hugie 08/15/18 01:31:48 AM
#93983   Even tho they claim it’s not their goal, TravO 08/15/18 12:44:24 AM
#93982   Biggest take over target I ever saw! Good Meq 08/14/18 10:34:34 PM
#93981   Pretty much does GREGG THE GREEK 08/14/18 07:15:32 PM
#93980   Sorry! Sent my reply wrong poster... It dukewin 08/14/18 07:13:47 PM
#93979   Fins please! Liuhisn 08/14/18 07:10:26 PM
#93978   That's hard to believe it, based on your dukewin 08/14/18 07:07:52 PM
#93977   If that's true I'm sure you are extremely BZstocks 08/14/18 06:13:41 PM
#93976   You upset with your $90,000 or that you TravO 08/14/18 06:11:12 PM
#93975   CEO of what company? Your home yoga studio? SK510 08/14/18 04:57:23 PM
#93974   Exactly! Nobody likes a complainer. techmover 08/14/18 04:55:02 PM
#93973   Hugie, seems you've already made a nice profit..... ScorpGirl 08/14/18 04:52:48 PM
#93972   Yes,then I will sell half and remaining shares Hugie 08/14/18 04:51:04 PM
#93971   when it goes to .25 - .50 it Penny Traders Club 08/14/18 04:46:26 PM
#93970   This one here ain't no scam. You will techmover 08/14/18 04:46:21 PM
#93969   Clearly, someone like to verbally abuse what he mfdesigner 08/14/18 04:45:57 PM
#93968   I keep over 40 tickers but all scams.Scams Hugie 08/14/18 04:44:45 PM
#93967   Really? Penny Traders Club 08/14/18 04:44:01 PM
#93966   Seriously. I wish I would have gotten in techmover 08/14/18 04:43:37 PM
#93965   Big spender! You spend a lot of time DDStocks 08/14/18 04:39:00 PM
#93964   I bought 1 400 000 at 0.0004 so Hugie 08/14/18 04:30:55 PM
#93963   Awesome! LOL a surfer 08/14/18 04:28:33 PM
#93962   Do you own shares, or are you waiting BZstocks 08/14/18 04:27:08 PM
#93961   SELL! SELL! SELL! PLEASE!!!!! techmover 08/14/18 04:26:44 PM
#93960   He too obviously has no clue! DDStocks 08/14/18 04:26:37 PM
#93959   I am waiting for fins but after so Hugie 08/14/18 04:25:59 PM
#93958   Agree- this says it all. BZstocks 08/14/18 04:25:57 PM
#93957   I actually prefer innovative Companies managed by techies. mfdesigner 08/14/18 04:23:44 PM
#93956   I-man I somewhat admire your voracity to try millionaireonpaper 08/14/18 04:22:59 PM
#93955   He must be in good company then lol BZstocks 08/14/18 04:21:50 PM
#93954   You are first who said I was right Hugie 08/14/18 04:19:07 PM
#93953   Sorry,holding for dollars myself. Shares not for sale. BZstocks 08/14/18 04:16:54 PM
#93952   Or perhaps the excellence of rrbb sees the Lizzybird 08/14/18 04:15:48 PM
#93951   PLEASE SELL!!!!!! techmover 08/14/18 04:15:31 PM
#93950   With a modest abilities of RRBB auditors they Hugie 08/14/18 04:11:38 PM
#93949   Think about it why would anyone spend so Penny Traders Club 08/14/18 04:09:56 PM
#93948   Sounds more like an attempt to shake our Penny Traders Club 08/14/18 04:08:13 PM
#93947   Well ain't nobody making you stay. Sell! sell! sell! techmover 08/14/18 04:08:02 PM
#93946   Yes we need to be saved! Please save DDStocks 08/14/18 04:05:48 PM
#93945   Because your are a good citizen you spend Penny Traders Club 08/14/18 04:04:49 PM
#93944   Two sides to everything and two sides to I-Man 08/14/18 04:02:52 PM
#93943   "Created an opportunity"? I-Man 08/14/18 04:02:08 PM
#93942   why would someone post about a stock they Penny Traders Club 08/14/18 03:59:20 PM
#93940   *BAM* doesn’t look like a P&D to me :-) Penny Traders Club 08/14/18 03:55:48 PM
#93939   We all know about the CE. In fact, Ace508 08/14/18 03:55:22 PM
#93938   Someone posted the below earlier. Feel free to SK510 08/14/18 03:50:14 PM